1. Home
  2. MTTR vs DVAX Comparison

MTTR vs DVAX Comparison

Compare MTTR & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTTR
  • DVAX
  • Stock Information
  • Founded
  • MTTR 2011
  • DVAX 1996
  • Country
  • MTTR United States
  • DVAX United States
  • Employees
  • MTTR N/A
  • DVAX N/A
  • Industry
  • MTTR Computer Software: Prepackaged Software
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTTR Technology
  • DVAX Health Care
  • Exchange
  • MTTR Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • MTTR 1.5B
  • DVAX 1.5B
  • IPO Year
  • MTTR N/A
  • DVAX 2004
  • Fundamental
  • Price
  • MTTR $4.78
  • DVAX $12.36
  • Analyst Decision
  • MTTR Hold
  • DVAX Buy
  • Analyst Count
  • MTTR 4
  • DVAX 2
  • Target Price
  • MTTR $5.13
  • DVAX $22.00
  • AVG Volume (30 Days)
  • MTTR 1.9M
  • DVAX 3.0M
  • Earning Date
  • MTTR 11-12-2024
  • DVAX 11-07-2024
  • Dividend Yield
  • MTTR N/A
  • DVAX N/A
  • EPS Growth
  • MTTR N/A
  • DVAX N/A
  • EPS
  • MTTR N/A
  • DVAX 0.15
  • Revenue
  • MTTR $165,426,000.00
  • DVAX $260,810,000.00
  • Revenue This Year
  • MTTR $11.03
  • DVAX $23.13
  • Revenue Next Year
  • MTTR $14.24
  • DVAX $19.60
  • P/E Ratio
  • MTTR N/A
  • DVAX $81.69
  • Revenue Growth
  • MTTR 3.82
  • DVAX N/A
  • 52 Week Low
  • MTTR $1.73
  • DVAX $9.74
  • 52 Week High
  • MTTR $4.99
  • DVAX $15.01
  • Technical
  • Relative Strength Index (RSI)
  • MTTR 56.69
  • DVAX 54.02
  • Support Level
  • MTTR $4.59
  • DVAX $11.51
  • Resistance Level
  • MTTR $4.88
  • DVAX $13.74
  • Average True Range (ATR)
  • MTTR 0.12
  • DVAX 0.58
  • MACD
  • MTTR -0.00
  • DVAX -0.10
  • Stochastic Oscillator
  • MTTR 76.19
  • DVAX 35.71

About MTTR Matterport Inc.

Matterport Inc is a spatial data company focused on digitizing and indexing the built world. Its all-in-one 3D data platform enables anyone to turn a space into an accurate and immersive digital twin which can be used to design, build, operate, promote, and understand any space. The Company recognizes revenue from subscription, license, services and sale of products. Majority of the revenue is generated in the form of subscription fees which it receives from the customers for providing them access to Matterport platform.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: